The impact of semaglutide on fusion rates following posterior lumbar fusion surgery in patients with type 2 diabetes
Semaglutide use is associated with a reduced risk of pseudarthrosis following posterior lumbar fusion in patients with T2DM. Further studies are warranted to elucidate the mechanisms underlying this potential benefit and to assess its implications in broader patient populations.
Authors
- Hong-Min Lin (ORCID: https://orcid.org/0000-0002-5335-2291)
- Kuan‐Yu Chi (ORCID: https://orcid.org/0000-0003-0763-8157)
- Junmin Song (ORCID: https://orcid.org/0000-0002-6150-6529)
- Hany Atwan (ORCID: https://orcid.org/0000-0002-4843-2393)
- Yu Chang
Institutions
- Jacobi Medical Center (US)
- Chi Mei Medical Center (TW)
- National Cheng Kung University Hospital (TW)
- Assiut University (EG)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1097/js9.0000000000002492
- Citations
- 2
- Primary Topic
- Spine and Intervertebral Disc Pathology
- Type
- article
- Field-Weighted Citation Impact
- 2.94